Bezlotoxumab (Zinplava) for Clostridium Difficile Infection: The First Monoclonal Antibody Approved to Prevent the Recurrence of a Bacterial Infection.

Autor:	Yuman Lee, Wai I. Lim, Bloom, Caitlyn I., Moore, Samantha, Chung, Elizabeth, Marzella, Nino
Předmět:	CLOSTRIDIUM diseases DRUG side effects DRUG approval MONOCLONAL antibodies ECONOMICS
Zdroj:	P&T: A Peer-Reviewed Journal for Managed Care & Formulary Management; Dec2017, Vol. 42 Issue 12, p735-738, 4p
Databáze:	Complementary Index
Externí odkaz:	Zobrazit plný text záznamu